Brigatinib(Alunbrig)

Another Name布格替尼、Alunbrig、安伯瑞、布吉他滨、布加替尼、卡布宁布格替尼、布吉替尼、AP26113

IndicationsThe treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) patients.